About 12,540 results

ALLMedicine™ Diabetic Retinopathy Center

Research & Reviews  4,381 results

Macrophage-Like Cell Density Is Increased in Proliferative Diabetic Retinopathy Charact...
Investigative Ophthalmology & Visual Science; Ong JX, Nesper PL et. al.

Aug 3rd, 2021 - To quantitatively characterize macrophage-like cells (MLCs) at the vitreoretinal interface in different severity stages of diabetic retinopathy (DR) using optical coherence tomography angiography (OCTA). The study included 72 eyes of 72 subjects: ...

Multi-label classification of fundus images based on graph convolutional network.
BMC Medical Informatics and Decision Making; Cheng Y, Ma M et. al.

Aug 1st, 2021 - Diabetic Retinopathy (DR) is the most common and serious microvascular complication in the diabetic population. Using computer-aided diagnosis from the fundus images has become a method of detecting retinal diseases, but the detection of multiple ...

Clinical Role of Smartphone Fundus Imaging in Diabetic Retinopathy and Other Neuro-reti...
Current Eye Research; Pujari A, Saluja G et. al.

Jul 31st, 2021 - Purpose: In today's life, many electronic gadgets have the potential to become invaluable health care devices in future. The gadgets in this category include smartphones, smartwatches, and others. Till now, smartphone role has been highlighted on ...

see more →

Guidelines  5 results

Diabetic Retinopathy Preferred Practice Pattern®.
Ophthalmology Flaxel CJ, Adelman RA et. al.

Nov 24th, 2019 - Diabetic Retinopathy Preferred Practice Pattern®.|2019|Flaxel CJ,Adelman RA,Bailey ST,Fawzi A,Lim JI,|standards,diagnosis,epidemiology,therapy,organization & administration,standards,

Excerpt from the Canadian Ophthalmological Society evidence-based clinical practice gui...
Canadian Journal of Ophthalmology. Journal Canadien D'oph... Hooper P, Boucher MC et. al.

Oct 28th, 2017 - Excerpt from the Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of diabetic retinopathy.|2017|Hooper P,Boucher MC,Cruess A,Dawson KG,Delpero W,|epidemiology,epidemiology,diagnosis,epidemiology,ther...

Diabetic retinopathy and maculopathy.
Experimental and Clinical Endocrinology & Diabetes : Offi... Hammes HP, Lemmen KD et. al.

Jul 12th, 2014 - Diabetic retinopathy and maculopathy.|2014|Hammes HP,Lemmen KD,Bertram B, ,|diagnosis,epidemiology,therapy,complications,epidemiology,complications,epidemiology,diagnosis,epidemiology,etiology,therapy,standards,standards,diagnosis,epidemiology,eti...

Management paradigms for diabetic macular edema.
American Journal of Ophthalmology; Mitchell P, Wong TY et. al.

Nov 26th, 2013 - To provide evidence-based recommendations for diabetic macular edema (DME) management based on updated information from publications on DME treatment modalities. Perspective. A literature search for "diabetic macular edema" or "diabetic maculopath...

Rationale for the diabetic retinopathy clinical research network treatment protocol for...
Ophthalmology , et. al.

Dec 6th, 2011 - To describe the underlying principles used to develop a web-based algorithm that incorporated intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema (DME) in a Diabetic Retinopathy Clinical Research N...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  276 results

Pars Plana Vitrectomy With Internal Limiting Membrane Peeling Versus Intravitreal Ziv-Aflibercept for Treatment-Naïve Diabetic Macular Edema

May 7th, 2020 - Diabetic retinopathy is the number one cause of vision loss in working-age adults, and macular edema is the most frequent cause of visual impairment in diabetic patients. Diabetic macular edema (DME) has been treated by a number of different modal...

Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Vitreous Hemorrhaging

May 6th, 2020 - Proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME) frequently occur together in patients with diabetic retinopathy In the landmark study Protocol S, about 30% of PDR subjects had DME at baseline and 53% of subjects receiving...

Silicone Oil Versus Long-acting Gas Tamponade in Proliferative Diabetic Retinopathy Patients With High-grade Vitreoretinal Adhesion Undergoing Vitrectomy

May 6th, 2020 - Severe vision loss in patients with proliferative diabetic retinopathy (PDR) frequently results from complications related to neovascularization and fibrovascular proliferation. Patients with PDR are typically considered candidates for pars plana ...

A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.

May 5th, 2020 - The main objective is to evaluate ocular and systemic safety and tolerability of BI 1467335 as well as whether BI 1467335 monotherapy has a potential to improve retinal lesions in patients with moderately severe Non-proliferative diabetic retinopa...

Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy

Mar 26th, 2020 - Diabetic retinopathy is a diabetes microvascular complication due to an insufficient oxygen supply to its endothelial cells in states of constant hyperglycemia. This entity is classified in two main categories: non-proliferative diabetic retinopat...

see more →

News  344 results

5G Network Enables Remote Laser Treatment of Diabetic Retinopathy

Jul 19th, 2021 - NEW YORK (Reuters Health) - The enhanced telemedicine capacity of the 5G high-speed wireless system has allowed remote real-time retinal laser telephotocoagulation in patients with diabetic retinopathy (DR), according to a study conducted in China...

Do Anti-VEGF Injections for Diabetic Retinopathy Impact Mortality?

Jul 8th, 2021 - The use of anti-vascular endothelial growth factor injections has been linked to an increased risk of mortality in patients with diabetic retinopathy in a new study, sounding a note of caution regarding the cardiovascular safety of these agents in...

Aflibercept Won't Help Vision in Early Diabetic Retinopathy

Mar 31st, 2021 - Intravitreal injections with aflibercept (Eylea) don't improve the visual acuity of people with nonproliferative diabetic retinopathy (NPDR), researchers say. The treatments do reduce the risk for center-involved diabetic macular edema and prolife...

Bariatric Surgery May Curb Diabetic Eye Disease Incidence but Worsen Existing Retinopathy

Jan 25th, 2021 - NEW YORK (Reuters Health) - Bariatric surgery was associated with fewer cases of diabetic retinopathy (DR), but early worsening was more severe in patients who already had the condition, a systematic review and meta-analysis reveals. "There are he...

Surgery Equals Drug Treatment for Bleeding in Diabetic Retinopathy

Dec 30th, 2020 - In the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, intraocular injection with anti–vascular endothelial growth factor (VEGF) shows similar efficacy to that of vitrectomy with photocoagulation; however, patients common...

see more →

Patient Education  6 results see all →